Citation: C. Louden et Dg. Morgan, Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entitiesfor human clinical trials, PHARM TOX, 89(4), 2001, pp. 158-170
Citation: Ca. Goss et al., Case of enantiomer impurity identification by normal-phase chiral high-performance liquid chromatography with optical rotation and mass spectrometricdetection, J CHROMAT A, 878(1), 2000, pp. 35-43
Authors:
Bugelski, PJ
Herzyk, DJ
Rehm, S
Harmsen, AG
Gore, EV
Williams, DM
Maleeff, BE
Badger, AM
Truneh, A
O'Brien, SR
Macia, RA
Wier, PJ
Morgan, DG
Hart, TK
Citation: Pj. Bugelski et al., Preclinical development of keliximab, a Primatized (TM) anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model andsafety studies, HUM EXP TOX, 19(4), 2000, pp. 230-243
Authors:
Bugelski, PJ
Atif, U
Molton, S
Toeg, I
Lord, PG
Morgan, DG
Citation: Pj. Bugelski et al., A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicology, PHARM RES, 17(10), 2000, pp. 1265-1272
Authors:
Holcomb, LA
Gordon, MN
Benkovic, SA
Morgan, DG
Citation: La. Holcomb et al., A beta and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity, MECH AGE D, 112(2), 2000, pp. 135-152
Authors:
Morgan, DG
Menetret, JF
Radermacher, M
Neuhof, A
Akey, IV
Rapoport, TA
Akey, CW
Citation: Dg. Morgan et al., A comparison of the yeast and rabbit 80 S ribosome reveals the topology ofthe nascent chain exit tunnel, inter-subunit bridges and mammalian rRNA expansion segments, J MOL BIOL, 301(2), 2000, pp. 301-321
Citation: Dg. Morgan et Nj. Stewart, The physical Environment of special care units: Needs of residents with dementia from the perspective of staff and family caregivers, QUAL HEAL R, 9(1), 1999, pp. 105-118
Citation: Dg. Morgan, 'Please see and advise': a qualitative study of patients' experiences of psychiatric outpatient care, SOC PSY PSY, 34(8), 1999, pp. 442-450
Authors:
Wright, KL
Morgan, DG
Yu, X
Goss, JR
Salbaum, JM
Duff, K
Gordon, MN
Citation: Kl. Wright et al., Mice transgenic for a human amyloid precursor protein promoter-lacZ reporter construct - Appropriate cell-type expression, but not regulation in brain, J MOL NEURO, 13(1-2), 1999, pp. 111-120
Authors:
Pennypacker, KR
Hernandez, H
Benkovic, S
Morgan, DG
Willing, AE
Sanberg, PR
Citation: Kr. Pennypacker et al., Induction of presenilins in the rat brain after middle cerebral arterial occlusion, BRAIN RES B, 48(5), 1999, pp. 539-543
Authors:
Stewart, NJ
Hiscock, M
Morgan, DG
Murphy, PB
Yamamoto, M
Citation: Nj. Stewart et al., Development and psychometric evaluation of the Environment-Behavior Interaction Code (EBIC), NURS RES, 48(5), 1999, pp. 260-268
Authors:
Morgan, DG
Kulkarni, RN
Hurley, JD
Wang, ZL
Wang, RM
Ghatei, MA
Karlsen, AE
Bloom, SR
Smith, DM
Citation: Dg. Morgan et al., Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells, DIABETOLOG, 41(12), 1998, pp. 1482-1491